This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University of Massachusetts. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations of Jillian Caiazzi in SARS-CoV-2 Modulation
Introduction
Jillian Caiazzi is an accomplished inventor based in Boston, MA. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides for the modulation of SARS-CoV-2. Her work is crucial in the ongoing fight against COVID-19.
Latest Patents
Jillian Caiazzi holds a patent for "Oligonucleotides for SARS-CoV-2 modulation." This patent discloses novel SARS-CoV-2 targeting sequences. The invention provides innovative oligonucleotides aimed at treating SARS-CoV-2 infections, showcasing her commitment to advancing medical science.
Career Highlights
Jillian is affiliated with the University of Massachusetts, where she continues her research and development efforts. Her work at the university allows her to collaborate with other leading scientists in the field.
Collaborations
Some of her notable coworkers include Anastasia Khvorova and Jonathan Watts. Their collaborative efforts contribute to the advancement of research in the area of viral modulation.
Conclusion
Jillian Caiazzi's innovative work in developing oligonucleotides for SARS-CoV-2 modulation highlights her significant role in biotechnology. Her contributions are vital in addressing the challenges posed by viral infections.